| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Davor Galetović, Lovro Bojić, Kajo Bućan, Dobrila Karlica, Mladen Lesin, Ljubo Znao. The role of oxidative stress after retinal laser photocoagulation in nonproliferative diabetic retinopathy. Collegium antropologicum. vol 35. issue 3. 2011-12-02. PMID:22053564. |
diabetic retinopathy (dr) represents the most common chronic complication of diabetes, and it is the leading cause of new cases of blindness in patients between 20-74 years old in developed countries. |
2011-12-02 |
2023-08-12 |
Not clear |
| Tiffany Frey, David A Antonett. Alterations to the blood-retinal barrier in diabetes: cytokines and reactive oxygen species. Antioxidants & redox signaling. vol 15. issue 5. 2011-11-22. PMID:21294655. |
diabetic retinopathy (dr) is a leading cause of blindness in western society. |
2011-11-22 |
2023-08-12 |
Not clear |
| Francisco Jiménez-Ramírez, Raúl Pére. Diabetic retinopathy education and screening at the community pharmacy in Puerto Rico. Puerto Rico health sciences journal. vol 30. issue 3. 2011-11-15. PMID:21932716. |
diabetic retinopathy (dr), the most common diabetes-related eye disorder, is associated with poor glucose control and is the most frequent cause of adult-onset blindness. |
2011-11-15 |
2023-08-12 |
Not clear |
| Wenbo Zhang, Hua Liu, Mohamed Al-Shabrawey, Robert W Caldwell, Ruth B Caldwel. Inflammation and diabetic retinal microvascular complications. Journal of cardiovascular disease research. vol 2. issue 2. 2011-11-10. PMID:21814413. |
diabetic retinopathy (dr) is one of the most common complications of diabetes and is a leading cause of blindness in people of the working age in western countries. |
2011-11-10 |
2023-08-12 |
Not clear |
| Xiang Li, Xiangxia Luo, Xin Lu, Junguo Duan, Guowang X. Metabolomics study of diabetic retinopathy using gas chromatography-mass spectrometry: a comparison of stages and subtypes diagnosed by Western and Chinese medicine. Molecular bioSystems. vol 7. issue 7. 2011-09-28. PMID:21559540. |
diabetic retinopathy (dr) is a serious microvascular syndrome of diabetes, and is one of the most frequent causes of blindness in the world. |
2011-09-28 |
2023-08-12 |
Not clear |
| Georgina V Bixler, Heather D Vanguilder, Robert M Brucklacher, Scot R Kimball, Sarah K Bronson, Willard M Freema. Chronic insulin treatment of diabetes does not fully normalize alterations in the retinal transcriptome. BMC medical genomics. vol 4. 2011-09-09. PMID:21575160. |
diabetic retinopathy (dr) is a leading cause of blindness in working age adults. |
2011-09-09 |
2023-08-12 |
Not clear |
| Beatrix Kovacs, Stephen Lumayag, Colleen Cowan, Shunbin X. MicroRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats. Investigative ophthalmology & visual science. vol 52. issue 7. 2011-09-01. PMID:21498619. |
diabetic retinopathy (dr) is one of the leading causes of blindness. |
2011-09-01 |
2023-08-12 |
rat |
| Jean Claude Ansquer, Dominique Crimet, Christelle Fouche. Fibrates and statins in the treatment of diabetic retinopathy. Current pharmaceutical biotechnology. vol 12. issue 3. 2011-08-26. PMID:20939802. |
diabetic retinopathy (dr) is one of the leading risk factors and causes of blindness worldwide. |
2011-08-26 |
2023-08-12 |
Not clear |
| Ying Yang, Melvin R Hayden, Susan Sowers, Sarika V Bagree, James R Sower. Retinal redox stress and remodeling in cardiometabolic syndrome and diabetes. Oxidative medicine and cellular longevity. vol 3. issue 6. 2011-07-26. PMID:21307645. |
diabetic retinopathy (dr) is a significant cause of global blindness; a major cause of blindness in the united states in people aged between 20-74. |
2011-07-26 |
2023-08-12 |
rat |
| Audrey Karperien, Herbert F Jelinek, Jorge J G Leandro, João V B Soares, Roberto M Cesar, Alan Lucki. Automated detection of proliferative retinopathy in clinical practice. Clinical ophthalmology (Auckland, N.Z.). vol 2. issue 1. 2011-07-20. PMID:19668394. |
timely intervention for diabetic retinopathy (dr) lessens the possibility of blindness and can save considerable costs to health systems. |
2011-07-20 |
2023-08-12 |
Not clear |
| Louis K Chang, David Sarra. Current and future approaches in the prevention and treatment of diabetic retinopathy. Clinical ophthalmology (Auckland, N.Z.). vol 2. issue 2. 2011-07-14. PMID:19668733. |
diabetic retinopathy (dr) is a major cause of blindness worldwide and is the number one cause of blindness in working-age individuals in developed countries. |
2011-07-14 |
2023-08-12 |
Not clear |
| Mohamed Amin Turki, Andreea-Mádálina Crai. [The risk of blindness in diabetic retinopathy]. Oftalmologia (Bucharest, Romania : 1990). vol 54. issue 4. 2011-06-10. PMID:21516864. |
progression of dr leads finally to blindness! |
2011-06-10 |
2023-08-12 |
Not clear |
| Kara McArthur, Biao Feng, Yuexiu Wu, Shali Chen, Subrata Chakrabart. MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy. Diabetes. vol 60. issue 4. 2011-06-06. PMID:21357793. |
diabetic retinopathy (dr) is a leading cause of blindness. |
2011-06-06 |
2023-08-12 |
Not clear |
| M Mvitu Muaka, B Longo-Mbenza, D Kaimbo Wa Kaimb. [Frequency and causes of blindness and poor vision in Congolese diabetic patients]. Le Mali medical. vol 24. issue 3. 2011-05-26. PMID:20093218. |
to determine the frequency and the causes of blindness and visual impairment among patients with diabetes mellitus from dr congo. |
2011-05-26 |
2023-08-12 |
Not clear |
| Will Whitmire, Mohammed Mh Al-Gayyar, Mohammed Abdelsaid, Bilal K Yousufzai, Azza B El-Remess. Alteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far. Molecular vision. vol 17. 2011-05-26. PMID:21293735. |
diabetic retinopathy (dr) is a leading cause of blindness in american adults. |
2011-05-26 |
2023-08-12 |
Not clear |
| Will Whitmire, Mohammed Mh Al-Gayyar, Mohammed Abdelsaid, Bilal K Yousufzai, Azza B El-Remess. Alteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far. Molecular vision. vol 17. 2011-05-26. PMID:21293735. |
over the years, dr has been perceived as a vascular disease characterized by vascular permeability, macular edema, and neovascularization that can lead to blindness. |
2011-05-26 |
2023-08-12 |
Not clear |
| Zhao-Yang Wang, Ke-Ke Zhao, Pei-Quan Zha. Erythropoietin therapy for early diabetic retinopathy through its protective effects on retinal pericytes. Medical hypotheses. vol 76. issue 2. 2011-05-23. PMID:21051154. |
diabetic retinopathy (dr) is a leading cause of acquired blindness among the people at working age. |
2011-05-23 |
2023-08-12 |
Not clear |
| Fadia T Shaya, Mohammad Aljawad. Diabetic retinopathy. Clinical ophthalmology (Auckland, N.Z.). vol 1. issue 3. 2011-05-10. PMID:19668479. |
among adults aged 20-74, diabetic retinopathy (dr) is the most frequent cause of blindness. |
2011-05-10 |
2023-08-12 |
Not clear |
| Ehud Rechtman, Alon Harris, Hanna J Garzozi, Thomas A Ciull. Pharmacologic therapies for diabetic retinopathy and diabetic macular edema. Clinical ophthalmology (Auckland, N.Z.). vol 1. issue 4. 2011-05-05. PMID:19668515. |
diabetic retinopathy (dr) and diabetic macular edema (dme) are leading causes of blindness in the working-aged population of most developed countries. |
2011-05-05 |
2023-08-12 |
Not clear |
| Francesco Bosci. Current approaches to the management of diabetic retinopathy and diabetic macular oedema. Drugs. vol 70. issue 16. 2011-04-27. PMID:20964459. |
diabetic retinopathy (dr) is a major cause of blindness in europe and north america, and the incidence is expected to increase in parallel with the rising incidence of diabetes mellitus. |
2011-04-27 |
2023-08-12 |
Not clear |